NBAT-1, the lncRNA neuroblastoma-associated transcript-1, has been identified as an independent prognostic marker for the clinical outcome in patients with NB [46,47], non-small cell lung cancer (NSCLC) [48] and in oesophageal cancer [49], and studies also proposed its association with hepatocellular carcinoma (HCC) [50], renal carcinoma [51,52], lung [53] and breast cancer [54], tumorigenesis, proliferation, migration and invasion [47]. This evidence concerns the gene NBAT1 and non-small cell lung carcinoma.